Statistics

Total Visits

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer83

Select a period of time:

Number of views in the range

Views
Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer7

Views

Views
September 20251
October 20251
November 20253
December 20250
January 20261
February 20260
March 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom2
Brazil2
Finland1
Honduras1
United States1
 

Top cities views

Views
Dallas1
Helsinki1
Marabá1
Palmares do Sul1
Tegucigalpa1